Scroll
A Customer-centric, Innovative
and Reliable CDMO with Global Solutions
One-stop Services and Solutions
Small Molecules CDMO Services
Porton End-to-end Small Molecule CDMO Service Platform offers comprehensive CMC solutions for small molecule drugs through our advanced technical capabilities. Our services encompass INT and DS process development and manufacturing, formulation development and DP (drug product) manufacturing, comprehensive quality research, and IND/NDA filing support.
More
TIDES CDMO Services
Porton One-stop Peptide & Oligonucleotide Drug CDMO Service Platform provides comprehensive services for peptide drugs and small nucleic acid drugs, including early research, process development and manufacturing, formulation development and DP manufacturing, analytical method development and validation, as well as global regulatory affairs support.
More
Biologics and Conjugates CDMO Services
Porton One-stop Biologics and Conjugates CDMO Service Platform offers comprehensive services for biologics and conjugate drugs (ADC, AOC, DAC, PDC, RDC), including early research, process development and manufacturing, formulation development and DP (drug product) manufacturing, analytical method development and validation, and global new drug registration affairs support.
More
Advanced Therapy Medicinal Products CRO & CDMO Services
Porton Advanced Solutions provides end-to-end CRO and CDMO services, including cell banking, process development, analytical development, GMP manufacturing, fill & finish, and testing services for plasmids, viral vectors, cell therapy, bacterial vector and nucleic acid therapeutics. Our support spans from research, pre-clinical, clinical, to commercial stages.
More
Global Presence
Global Presence
China
-
Chongqing
Headquarters, R&D Center
R&D and GMP Manufacturing
DS & DP, HP -
Shanghai
Headquarters, R&D Center
R&D and GMP Manufacturing
DS & DP, HP
TIDES
Biologics and Conjugates
Yichun, Jiangxi
GMP Manufacturing, RSM & INT
Xiaogan, Hubei
Manufacturing, RSM & INT
Suzhou, Jiangsu
R&D and GMP Manufacturing
ATMP
Switzerland
America
Environmental, Social and Corporate Governance
At Porton, we are guided by the ESG principles of green development, promoting common progress, building a healthy society together, and enhancing corporate governance. These principles drive our sustainable development and our efforts to create greater environmental and social value.
News
Sep 17, 2026
Porton Congratulates Partner Acepodia on FDA Clearance of IND Application for ACE723, a Dual-Payload ADC
Sep 15, 2026
Porton Chongqing Liangjiang Drug Product Manufacturing Site Earns Recertification of ISO 14001 & ISO 45001
Sep 01, 2026
Porton to Showcase End-to-End CDMO Expertise at CPHI Milan 2026
